Jaguar Animal Health, Inc.

Ticker JAGX

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in San Francisco, California

Jaguar Animal Health, Inc. is an animal health company focused on developing and commercializing first-in-class gastrointestinal products for companion and production animals, foals, and high value horses. Canalevia™ is Jaguar’s lead prescription drug product candidate, intended for the treatment of various forms of diarrhea in dogs.

Visit website

REPORT RATINGS

4.8 / 5.0 (186)

Jaguar Animal Health, Inc. reports have an aggregate usefulness score of 4.8 based on 186 reviews.

Jaguar Animal Health, Inc.

Most Recent Annual Report

MOST RECENT 2023 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Jaguar Animal Health, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.